View ValuationCore Scientific 将来の成長Future 基準チェック /56Core Scientificは、84.1%と36.8%でそれぞれ年率84.1%で利益と収益が成長すると予測される一方、EPSはgrowで94%年率。主要情報84.1%収益成長率93.95%EPS成長率Software 収益成長60.0%収益成長率36.8%将来の株主資本利益率n/aアナリストカバレッジGood最終更新日03 Aug 2026今後の成長に関する最新情報Breakeven Date Change • May 11Forecast breakeven date pushed back to 2027The 13 analysts covering Core Scientific previously expected the company to break even in 2026. New consensus forecast suggests losses will reduce by 6.5% to 2026. The company is expected to make a profit of US$229.2m in 2027. Average annual earnings growth of 109% is required to achieve expected profit on schedule.すべての更新を表示Recent updatesお知らせ • Jul 30Core Scientific, Inc. to Report Q2, 2026 Results on Jul 28, 2026Core Scientific, Inc. announced that they will report Q2, 2026 results Pre-Market on Jul 28, 2026お知らせ • Jul 29Core Scientific, Inc. Announces Appointment of Mark W. Adams to Board of Directors, Effective July 29, 2026Core Scientific, Inc. announced the appointment of Mark W. Adams to its Board of Directors, effective July 29, 2026. With the addition of Mr. Adams, Core Scientific’s Board expanded to seven directors. Mr. Adams age 62, brings over three decades of technology leadership experience across the AI infrastructure, semiconductors, storage, digital media, and enterprise hardware industries. Most recently, he served as President and Chief Executive Officer of Penguin Solutions, Inc. (formerly SMART Global Holdings, Inc.) from 2020 until 2026. During his tenure, he led the company through a multi-year repositioning toward AI infrastructure solutions, including memory solutions and IT services serving enterprise and hyperscale customers. Prior to Penguin, Mr. Adams spent ten years at Micron Technology, Inc., where he held a series of senior leadership roles, including serving as President for four years. Mr. Adams currently serves on the boards of directors of Seagate Technology Holdings Public Limited Company, where he has served as a director since 2024, and Cadence Design Systems, Inc., where he has served as a director since 2015. Mr. Adams holds an MBA from Harvard University and a B.A. from Boston College.Reported Earnings • Jul 28Second quarter 2026 earnings released: US$3.55 loss per share (vs US$0.84 loss in 2Q 2025)Second quarter 2026 results: US$3.55 loss per share (further deteriorated from US$0.84 loss in 2Q 2025). Revenue: US$164.2m (up 109% from 2Q 2025). Net loss: US$1.16b (loss widened 331% from 2Q 2025). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 9.3% growth forecast for the Software industry in Italy.New Risk • Jul 01New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$471m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$471m free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-US$1.3b).お知らせ • May 27Core Scientific, Inc. Appoints Steve Smith to Its Board of Directors and Nominating and Corporate Governance Committee, Effective May 26, 2026Core Scientific, Inc. announced the appointment of Steve Smith to its Board of Directors, effective May 26, 2026. Mr. Smith will also serve on the Company’s Nominating and Corporate Governance Committee. Mr. Smith, age 70, brings over 35 years of leadership experience in the data center, digital infrastructure and technology industries. He is currently Chief Executive Officer of Zayo Group, a global internet network provider since 2020. Previously, Mr. Smith served as CEO and President of Equinix from 2007 to 2018, where he led the company in scaling annual revenue from approximately $400 million to more than $4 billion and oversaw the successful integration of more than 20 acquisitions. Prior to Equinix, Mr. Smith held senior leadership roles at HP Services, Lucent Technologies and Electronic Data Systems Corporation. Mr. Smith currently serves on the boards of directors of Zayo and NEXTDC, a publicly traded Australian data center company. He graduated from the U.S. Military Academy at West Point with a Bachelor of Science in Engineering.Breakeven Date Change • May 11Forecast breakeven date pushed back to 2027The 13 analysts covering Core Scientific previously expected the company to break even in 2026. New consensus forecast suggests losses will reduce by 6.5% to 2026. The company is expected to make a profit of US$229.2m in 2027. Average annual earnings growth of 109% is required to achieve expected profit on schedule.Reported Earnings • May 07First quarter 2026 earnings released: US$1.08 loss per share (vs US$0.17 loss in 1Q 2025)First quarter 2026 results: US$1.08 loss per share (further deteriorated from US$0.17 loss in 1Q 2025). Revenue: US$115.2m (up 45% from 1Q 2025). Net loss: US$347.2m (loss widened US$293.5m from 1Q 2025). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Italy.お知らせ • Apr 26Core Scientific, Inc. to Report Q1, 2026 Results on May 06, 2026Core Scientific, Inc. announced that they will report Q1, 2026 results After-Market on May 06, 2026お知らせ • Apr 01Core Scientific, Inc., Annual General Meeting, May 12, 2026Core Scientific, Inc., Annual General Meeting, May 12, 2026.Reported Earnings • Mar 03Full year 2025 earnings released: US$0.91 loss per share (vs US$4.39 loss in FY 2024)Full year 2025 results: US$0.91 loss per share (improved from US$4.39 loss in FY 2024). Revenue: US$319.0m (down 38% from FY 2024). Net loss: US$288.6m (loss narrowed 74% from FY 2024). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in Italy.お知らせ • Mar 03Core Scientific, Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2025Core Scientific, Inc. reported impairment of property, plant and equipment of $11,359,000 for the fourth quarter ended December 31, 2025 against $25,608,000 a year ago.お知らせ • Feb 23Core Scientific, Inc. to Report Q4, 2025 Results on Mar 02, 2026Core Scientific, Inc. announced that they will report Q4, 2025 results After-Market on Mar 02, 2026お知らせ • Feb 20Core Scientific, Inc. Announces Jordan Levy Notifies That He Will Not Stand for Re-Election as Chairman of the Board of DirectorsOn February 18, 2026, Jordan Levy, the Chairman of the Board of Directors, notified the Core Scientific, Inc. and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. His decision not to stand for re-election is not due to any disagreement with the Company.Board Change • Nov 25High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Eric Weiss is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.業績と収益の成長予測BIT:1CORZ - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/20281,738294-4,984774912/31/20271,153121-3,1296521612/31/2026672-1,513-943438166/30/2026440-1,633-968520N/A3/31/2026355-1,072-471573N/A12/31/2025319-281-461278N/A9/30/2025334-527-354135N/A6/30/2025348-723-2578N/A3/31/2025411-1,514-172-24N/A12/31/2024511-1,245-5243N/A9/30/2024558-1,133-2751N/A6/30/2024575-831151N/A3/31/2024561-352067N/A12/31/2023502-2464865N/A9/30/2023482-48614159N/A6/30/2023531-879-46102N/A3/31/2023568-1,681-95229N/A12/31/2022640-2,146-386205N/A9/30/2022821-1,651-195199N/A6/30/2022771-1,233-260206N/A3/31/2022683-426-393-76N/A12/31/202154447-116-57N/A9/30/2021266-16-294-172N/A6/30/2021163-1-178-130N/A3/31/202194-6-24-3N/A12/31/202060-23-25-24N/A12/31/201960-12N/A-1N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 1CORZは今後 3 年間で収益性が向上すると予測されており、これは 貯蓄率 ( 3.4% ) よりも高い成長率であると考えられます。収益対市場: 1CORZ今後 3 年間で収益性が向上すると予想されており、これは市場平均を上回る成長と考えられます。高成長収益: 1CORZ今後 3 年以内に収益を上げることが予想されます。収益対市場: 1CORZの収益 ( 36.8% ) Italian市場 ( 6.1% ) よりも速いペースで成長すると予測されています。高い収益成長: 1CORZの収益 ( 36.8% ) 20%よりも速いペースで成長すると予測されています。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 1CORZの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YSoftware 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/08/10 00:04終値2026/08/10 00:00収益2026/06/30年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社のGitHubページでご覧いただけます。また、レポートの活用方法に関するガイドやYouTubeのチュートリアルも用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Core Scientific, Inc. 16 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。23 アナリスト機関Andrew Charles BealeArete Research Services LLPRamsey El-AssalBarclaysGautam ChhuganiBernstein20 その他のアナリストを表示
Breakeven Date Change • May 11Forecast breakeven date pushed back to 2027The 13 analysts covering Core Scientific previously expected the company to break even in 2026. New consensus forecast suggests losses will reduce by 6.5% to 2026. The company is expected to make a profit of US$229.2m in 2027. Average annual earnings growth of 109% is required to achieve expected profit on schedule.
お知らせ • Jul 30Core Scientific, Inc. to Report Q2, 2026 Results on Jul 28, 2026Core Scientific, Inc. announced that they will report Q2, 2026 results Pre-Market on Jul 28, 2026
お知らせ • Jul 29Core Scientific, Inc. Announces Appointment of Mark W. Adams to Board of Directors, Effective July 29, 2026Core Scientific, Inc. announced the appointment of Mark W. Adams to its Board of Directors, effective July 29, 2026. With the addition of Mr. Adams, Core Scientific’s Board expanded to seven directors. Mr. Adams age 62, brings over three decades of technology leadership experience across the AI infrastructure, semiconductors, storage, digital media, and enterprise hardware industries. Most recently, he served as President and Chief Executive Officer of Penguin Solutions, Inc. (formerly SMART Global Holdings, Inc.) from 2020 until 2026. During his tenure, he led the company through a multi-year repositioning toward AI infrastructure solutions, including memory solutions and IT services serving enterprise and hyperscale customers. Prior to Penguin, Mr. Adams spent ten years at Micron Technology, Inc., where he held a series of senior leadership roles, including serving as President for four years. Mr. Adams currently serves on the boards of directors of Seagate Technology Holdings Public Limited Company, where he has served as a director since 2024, and Cadence Design Systems, Inc., where he has served as a director since 2015. Mr. Adams holds an MBA from Harvard University and a B.A. from Boston College.
Reported Earnings • Jul 28Second quarter 2026 earnings released: US$3.55 loss per share (vs US$0.84 loss in 2Q 2025)Second quarter 2026 results: US$3.55 loss per share (further deteriorated from US$0.84 loss in 2Q 2025). Revenue: US$164.2m (up 109% from 2Q 2025). Net loss: US$1.16b (loss widened 331% from 2Q 2025). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 9.3% growth forecast for the Software industry in Italy.
New Risk • Jul 01New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -US$471m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-US$471m free cash flow). Share price has been highly volatile over the past 3 months (13% average weekly change). Negative equity (-US$1.3b).
お知らせ • May 27Core Scientific, Inc. Appoints Steve Smith to Its Board of Directors and Nominating and Corporate Governance Committee, Effective May 26, 2026Core Scientific, Inc. announced the appointment of Steve Smith to its Board of Directors, effective May 26, 2026. Mr. Smith will also serve on the Company’s Nominating and Corporate Governance Committee. Mr. Smith, age 70, brings over 35 years of leadership experience in the data center, digital infrastructure and technology industries. He is currently Chief Executive Officer of Zayo Group, a global internet network provider since 2020. Previously, Mr. Smith served as CEO and President of Equinix from 2007 to 2018, where he led the company in scaling annual revenue from approximately $400 million to more than $4 billion and oversaw the successful integration of more than 20 acquisitions. Prior to Equinix, Mr. Smith held senior leadership roles at HP Services, Lucent Technologies and Electronic Data Systems Corporation. Mr. Smith currently serves on the boards of directors of Zayo and NEXTDC, a publicly traded Australian data center company. He graduated from the U.S. Military Academy at West Point with a Bachelor of Science in Engineering.
Breakeven Date Change • May 11Forecast breakeven date pushed back to 2027The 13 analysts covering Core Scientific previously expected the company to break even in 2026. New consensus forecast suggests losses will reduce by 6.5% to 2026. The company is expected to make a profit of US$229.2m in 2027. Average annual earnings growth of 109% is required to achieve expected profit on schedule.
Reported Earnings • May 07First quarter 2026 earnings released: US$1.08 loss per share (vs US$0.17 loss in 1Q 2025)First quarter 2026 results: US$1.08 loss per share (further deteriorated from US$0.17 loss in 1Q 2025). Revenue: US$115.2m (up 45% from 1Q 2025). Net loss: US$347.2m (loss widened US$293.5m from 1Q 2025). Revenue is forecast to grow 31% p.a. on average during the next 3 years, compared to a 11% growth forecast for the Software industry in Italy.
お知らせ • Apr 26Core Scientific, Inc. to Report Q1, 2026 Results on May 06, 2026Core Scientific, Inc. announced that they will report Q1, 2026 results After-Market on May 06, 2026
お知らせ • Apr 01Core Scientific, Inc., Annual General Meeting, May 12, 2026Core Scientific, Inc., Annual General Meeting, May 12, 2026.
Reported Earnings • Mar 03Full year 2025 earnings released: US$0.91 loss per share (vs US$4.39 loss in FY 2024)Full year 2025 results: US$0.91 loss per share (improved from US$4.39 loss in FY 2024). Revenue: US$319.0m (down 38% from FY 2024). Net loss: US$288.6m (loss narrowed 74% from FY 2024). Revenue is forecast to grow 36% p.a. on average during the next 3 years, compared to a 12% growth forecast for the Software industry in Italy.
お知らせ • Mar 03Core Scientific, Inc. Reports Impairment of Property, Plant and Equipment for the Fourth Quarter Ended December 31, 2025Core Scientific, Inc. reported impairment of property, plant and equipment of $11,359,000 for the fourth quarter ended December 31, 2025 against $25,608,000 a year ago.
お知らせ • Feb 23Core Scientific, Inc. to Report Q4, 2025 Results on Mar 02, 2026Core Scientific, Inc. announced that they will report Q4, 2025 results After-Market on Mar 02, 2026
お知らせ • Feb 20Core Scientific, Inc. Announces Jordan Levy Notifies That He Will Not Stand for Re-Election as Chairman of the Board of DirectorsOn February 18, 2026, Jordan Levy, the Chairman of the Board of Directors, notified the Core Scientific, Inc. and the Board of Directors that he will not stand for re-election at the 2026 Annual Meeting. His decision not to stand for re-election is not due to any disagreement with the Company.
Board Change • Nov 25High number of new and inexperienced directorsThere are 6 new directors who have joined the board in the last 3 years. The company's board is composed of: 6 new directors. No experienced directors. No highly experienced directors. Independent Director Eric Weiss is the most experienced director on the board, commencing their role in 2024. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.